ANIP
Price
$54.20
Change
+$0.85 (+1.59%)
Updated
Dec 23, 04:59 PM (EDT)
66 days until earnings call
ORGO
Price
$3.17
Change
+$0.12 (+3.93%)
Updated
Dec 23, 04:59 PM (EDT)
65 days until earnings call
Ad is loading...

ANIP vs ORGO

Header iconANIP vs ORGO Comparison
Open Charts ANIP vs ORGOBanner chart's image
ANI Pharmaceuticals
Price$54.20
Change+$0.85 (+1.59%)
Volume$2.96K
CapitalizationN/A
Organogenesis Holdings
Price$3.17
Change+$0.12 (+3.93%)
Volume$10.93K
CapitalizationN/A
ANIP vs ORGO Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. ORGO commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Hold and ORGO is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (ANIP: $53.35 vs. ORGO: $3.05)
Brand notoriety: ANIP and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 389% vs. ORGO: 238%
Market capitalization -- ANIP: $1.43B vs. ORGO: $374.78M
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ORGO is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 3 bullish TA indicator(s).

  • ANIP’s TA Score: 4 bullish, 5 bearish.
  • ORGO’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ANIP is a better buy in the short-term than ORGO.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а -5.73% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -10.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.39%. For the same industry, the average monthly price growth was -1.09%, and the average quarterly price growth was -8.83%.

Reported Earning Dates

ANIP is expected to report earnings on Feb 27, 2025.

ORGO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($1.43B) has a higher market cap than ORGO($375M). ANIP has higher P/E ratio than ORGO: ANIP (79.85) vs ORGO (70.25). ANIP YTD gains are higher at: -3.246 vs. ORGO (-25.428). ANIP has higher annual earnings (EBITDA): 107M vs. ORGO (36M). ANIP has more cash in the bank: 221M vs. ORGO (104M). ORGO has less debt than ANIP: ORGO (119M) vs ANIP (286M). ANIP has higher revenues than ORGO: ANIP (487M) vs ORGO (433M).
ANIPORGOANIP / ORGO
Capitalization1.43B375M381%
EBITDA107M36M297%
Gain YTD-3.246-25.42813%
P/E Ratio79.8570.25114%
Revenue487M433M112%
Total Cash221M104M213%
Total Debt286M119M240%
FUNDAMENTALS RATINGS
ANIP vs ORGO: Fundamental Ratings
ANIP
ORGO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9090
PRICE GROWTH RATING
1..100
6061
P/E GROWTH RATING
1..100
9311
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (82) in the Financial Conglomerates industry is in the same range as ANIP (90) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ORGO's Profit vs Risk Rating (100) in the Financial Conglomerates industry is in the same range as ANIP (100) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ORGO's SMR Rating (90) in the Financial Conglomerates industry is in the same range as ANIP (90) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Price Growth Rating (60) in the Pharmaceuticals Other industry is in the same range as ORGO (61) in the Financial Conglomerates industry. This means that ANIP’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's P/E Growth Rating (11) in the Financial Conglomerates industry is significantly better than the same rating for ANIP (93) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPORGO
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
72%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
69%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMUCX22.310.30
+1.36%
MFS Utilities C
MADVX18.990.23
+1.23%
BlackRock Equity Dividend Instl
AUUAX22.020.24
+1.10%
AB Select US Equity A
HDSVX18.670.03
+0.16%
Hodges Small Intrinsic Value Retail
COSNX9.88-0.01
-0.10%
Columbia Overseas Core Institutional

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-1.68%
DRRX - ANIP
38%
Loosely correlated
+10.72%
SNDL - ANIP
31%
Poorly correlated
+4.05%
PRPH - ANIP
29%
Poorly correlated
-6.52%
ORGO - ANIP
24%
Poorly correlated
-1.93%
PBH - ANIP
23%
Poorly correlated
+0.08%
More

ORGO and

Correlation & Price change

A.I.dvisor tells us that ORGO and AMRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGO and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-1.93%
AMRX - ORGO
32%
Poorly correlated
+0.39%
HROW - ORGO
30%
Poorly correlated
-0.61%
ACET - ORGO
29%
Poorly correlated
+5.78%
AMPH - ORGO
27%
Poorly correlated
-0.63%
HTSUF - ORGO
26%
Poorly correlated
N/A
More